We enjoyed discussing your research endeavors at the NorCal SOT Spring Symposium. Let’s keep the conversations going! Christopher Smoke, MBA, Michael Zamora, Mark P., Scott Boley, Norbert Makori, BVM, MSc, PhD, DABT, Steve Mason, Shannon Stancu-Goldberg #DrugDevelopment #Nonclinical #NorCalSOT
Altasciences
Research Services
Laval, Quebec 30,204 followers
Your partner in early-phase drug development. We simplify and streamline solutions so you can focus on what matters.
About us
Outsourcing made easy with a one-stop solution to early phase drug development. We are an integrated drug development solution company, offering pharmaceutical and biotechnology companies a proven, flexible approach that removes the need for multiple service providers during the early stages of drug development. Whether for one study or an end-to-end program, we help you reach critical decision-making milestones sooner by improving speed and ease from lead candidate selection to clinical proof of concept, and beyond. When partnering with Altasciences, you can experience up to 40% in time savings thanks to our integrated, one-stop solution offering. We strive to create a true partnership with our clients, our partners, and our colleagues that enables a mutually supporting relationship built on a combination of excellent science and solid communication. Helping sponsors get better drugs to the people who need them, faster, for over 25 years. Our full-service offering is always tailored to your specific research needs: - Preclinical research - Clinical pharmacology - Drug formulation - Manufacturing and analytical services - Bioanalysis - Program management - Medical writing - Biostatics - Data management - And so much more!
- Website
-
http://www.altasciences.com
External link for Altasciences
- Industry
- Research Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Laval, Quebec
- Type
- Privately Held
- Founded
- 1992
- Specialties
- Clinical Research, Clinical Trials, Phase I-II, Human Abuse Liability & Abuse Potential, Early Cardiac Safety & TQT, Biosimilars, Bioanalytical Laboratory, Analytical Services, Toxicology Study, CDMO, Safety Pharmacology, Preclinical Study, GLP / Non-GLP Study, IND-Enabling, NDA Submission, LCMS and LBA, Small and Large Molecule Bioanalysis, Research Support Services, Medical Writing, Clinical Project Management, and Pharmaceutical Manufacturing
Locations
Employees at Altasciences
Updates
-
INVITATION TO OUR EXCLUSIVE SYMPOSIUM—On June 6, let’s talk about all things drug development, including safety assessment, the use of specific species for gene therapy research, regulatory pathways to conduct first-In-human trials in Canada, incorporating AI in drug discovery, and the shift from UK academia to U.S. biotech. #LifeScience #DrugDevelopment #RegulatoryAffairs Register today! https://lnkd.in/gTsspiuQ
This content isn’t available here
Access this content and more in the LinkedIn app
-
INVITATION TO OUR EXCLUSIVE SYMPOSIUM—On June 6, let’s talk all things drug development, including safety assessment, the use of specific species for gene therapy research, regulatory pathways to conduct first-In-human trials in Canada, incorporating AI in drug discovery, and the shift from UK academia to U.S. biotech. #LifeScience #DrugDevelopment #RegulatoryAffairs
-
We’re all set up at the ASGCT 2024 conference! Visit Gretchen Green, Susan Ohorodnik, and Bridget Coyne at Booth #129 and let's chat about your gene and cell therapy programs. #DrugDevelopment #GeneTherapy #ASGCT2024
-
-
At Altasciences, your project takes center stage. Our scientists are committed to advancing ADC development with state-of-the-art equipment and expertise in ligand binding and mass spectrometry bioanalysis. Across our three purpose-built labs, we offer the industry's leading platforms for PK and PD studies, tailored to meet your project's specific requirements. Let's collaborate and drive therapeutic innovation together! #DrugDevelopment #LifeSciences #ADCs
-
Unveil the invisible with us at Booth #13 during the WRIB 2024 conference and explore our all-in-one bioanalytical solution! #WRIB #Bioanalysis #DrugDevelopment
-
-
Combining certain Phase II studies with the Phase I protocol gives you access to data sooner, for more informed go/no-go decisions early on in your program. This strategy makes it possible to: • accelerate drug development; • potentially waive certain later-phase studies; and • better allocate resources to maximize revenues and balance timelines. #DrugDevelopment #ClinicalResearch #ClinicalTrials
-
We are enjoying our time with you at the ARVO 2024 Annual Meeting in Seattle, WA! Stop by our Booth #1712 to chat. If you prefer, pre-book a time here, so we can meet when it’s convenient for you: https://lnkd.in/d-MtZzR6 #DrugManufacturing #Ophthalmology #ARVO2024
-
Do you have large molecules in your pipeline? Read our latest blog post to learn how to plan for a successful program: https://lnkd.in/eFEwDBDH #DrugDevelopment #Biomarkers #LifeSciences
-
Are you attending the CPHI North America conference? Join us to discover how Altasciences can fully support your drug development needs, including the manufacturing of your preclinical and clinical test material. You can also pre-book a time to chat with one of our CDMO experts here: https://lnkd.in/gH56PFp9 #DrugManufacturing #CDMO #CPHINA
-